Related Experiment Videos
Stimulated prostaglandin E2 release from rat skin, in vitro
S K Sauer1, D Schäfer, M Kress
1Institut für Physiologie und Experimentelle Pathophysiologie, Universität Erlangen-Nürnberg, Erlangen, Germany. sauer@physiologie1.uni-erlangen.de
Life Sciences
|June 17, 1998
Summary
This study introduces a novel rat skin model to measure prostaglandin E2 (PGE2) release, crucial for understanding pain signaling. Inflammatory mediators significantly increase PGE2 release, but low pH unexpectedly decreases it.
Area of Science:
- Pharmacology and Toxicology
- Neuroscience and Pain Research
- Biochemistry and Molecular Biology
Background:
- Bradykinin (BK) and low pH effects on nociceptors are partly mediated by prostaglandin release.
- Understanding the release of prostaglandins like PGE2 is vital for pain research.
- A novel in vitro rat skin model is proposed for studying nociception mediators.
Purpose of the Study:
- To establish and validate a novel in vitro rat skin model for measuring PGE2 release.
- To investigate the dose-dependent release of PGE2 induced by bradykinin (BK) and inflammatory mediators.
- To explore the effect of low pH on PGE2 release in the context of nociception.
Main Methods:
- Excised rat hindpaw skin flaps were mounted and perfused with synthetic interstitial fluid (SIF).
- Skin flaps were exposed to BK, or BK with histamine and serotonin, or low pH solutions.
- Eluted PGE2 was quantified using an enzyme immunoassay.
Main Results:
- BK and combinations of inflammatory mediators dose-dependently increased PGE2 release.
- Combined mediators induced significantly greater PGE2 release than BK alone.
- Low pH (6.1-6.4) significantly decreased PGE2 release, likely by inhibiting phospholipases.
Conclusions:
- The novel rat skin model effectively measures stimulated PGE2 release relevant to nociception.
- Inflammatory mediators enhance PGE2 release, contributing to pain signaling.
- Low pH's inhibitory effect on PGE2 release suggests complex interactions in pain modulation.